pubmed-article:17054108 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C1556084 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C0278601 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:17054108 | lifeskim:mentions | umls-concept:C1510810 | lld:lifeskim |
pubmed-article:17054108 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:17054108 | pubmed:dateCreated | 2006-11-27 | lld:pubmed |
pubmed-article:17054108 | pubmed:abstractText | The authors evaluated the long-term efficacy and side effects in patients with nonmetastatic, unilateral, inflammatory breast cancer (IBC) who received homogeneous treatment with intensive induction chemotherapy followed by a maintenance regimen. | lld:pubmed |
pubmed-article:17054108 | pubmed:language | eng | lld:pubmed |
pubmed-article:17054108 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17054108 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17054108 | pubmed:month | Dec | lld:pubmed |
pubmed-article:17054108 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:CholletPhilip... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:FumoleauPierr... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:MerroucheYaci... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:KerbratPierre... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:FargeotPierre... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:RocheHenriH | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:VeyretCorinne... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:ClaverePierre... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:LevyChristell... | lld:pubmed |
pubmed-article:17054108 | pubmed:author | pubmed-author:ChevallierBer... | lld:pubmed |
pubmed-article:17054108 | pubmed:copyrightInfo | (c) 2006 American Cancer Society. | lld:pubmed |
pubmed-article:17054108 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17054108 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17054108 | pubmed:volume | 107 | lld:pubmed |
pubmed-article:17054108 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17054108 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17054108 | pubmed:pagination | 2535-44 | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:meshHeading | pubmed-meshheading:17054108... | lld:pubmed |
pubmed-article:17054108 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:17054108 | pubmed:articleTitle | Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial. | lld:pubmed |
pubmed-article:17054108 | pubmed:affiliation | Department of Medical Oncology, Henri Becquerel Center, Rouen, France. cveyret@rouen.fnclcc.fr | lld:pubmed |
pubmed-article:17054108 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17054108 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:17054108 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17054108 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17054108 | lld:pubmed |